Top 5 Viewed Posts in October 2018.



Here is our list of top five viewed posts in October. 


POST #1:

Trazodone for Treatment of Major Depressive Disorder.


This post will answer following five questions on this topic:

  1. How is Trazodone different from SSRIs and SNRIs?

  2. What dose of Trazodone is effective for MDD treatment?

  3. What dose of Trazodone is effective for insomnia treatment (off label)?

  4. Is hypnotic dose of Trazodone effective for MDD treatment?

  5. How to initiate and titrate Trazodone for MDD treatment?

Click here for details:


POST #2:

Is Quetiapine 600 mg Superior to 300 mg for Bipolar I and II Depression?


This post will summarize two double blind randomized trials to answer this question.

Click here for details:


POST #3:

How Long to Continue Antipsychotics After Mania remission?


Q: What is the optimal duration for continuation of atypical antipsychotic adjunctive therapy after mania remission? 

Click here for details:


POST #4:

5-HT2A Receptor Antagonists for Neuroleptic Induced Akathisia.


This post will summarize three medications with 5-HT2A antagonist property: Mirtazapine, Trazodone and Mianserin.

Click here for details:


POST #5:

Psychosis Management in Parkinson’s Disease. 


Which Antipsychotic is Preferred for Management of Psychosis in Elderly with Parkinson’s Disease?

Click here for details:


Posts by Dr. Harvinder Singh, M.D.

Our Most Recent Book Publication:

Essentials of Inpatient Psychiatry

Related Articles